Neu REFIX β-glucan reduces muscle fibrosis in Duchenne muscular dystrophy MDX mice, in joint research with Dr. Yoshitsugu Aoki, NCNP, Tokyo, Japan.

Skeletal muscle fibrosis which leads to locomotor dysfunction in Duchenne Muscular Dystrophy (DMD) could be significantly reduced by oral consumption of Neu-REFIX beta 1,3-1,6 glucans alone for 45 days without any other drugs, in MDX mice model of DMD. This research was undertaken jointly with the team of Dr Yoshitsugu Aoki (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.ncnp.go.jp%2Fnin%2Fguide%2Fr_dna2%2Fgreeting_en.html&esheet=53620489&newsitemid=20231016033169&lan=en-U…